Affibody AB logo

Affibody AB

94 employees · est. 1998 · Sweden

VS
MindImmune Therapeutics, Inc. logo

MindImmune Therapeutics, Inc.

12 employees · est. 2016 · Kingston, United States

Affibody AB is the older company (1998 vs 2016); Affibody AB is the larger of the two.

Side-by-Side Comparison

Affibody AB MindImmune Therapeutics, Inc.
Founded
1998 older 2016
Headquarters
Sweden Kingston, United States
Employees
94 larger 12
Industry
Biotechnology, Health Care Biotechnology, Pharmaceutical
Funding Stage
Debt Financing Series A
Total Funding
$220.00M $13.65M
Funding Rounds
3 3
Services
Development of radiopharmaceutical therapeutics, Research and development in radioligand therapies, Partnerships in immunology Not tracked yet
Target Customers
Cancer patients, Healthcare providers, Pharmaceutical partners Not tracked yet
Taxonomy
Not tracked yet Neuroinflammation, Neuroscience, Neuroimmunology, Pharmaceutical R&D, Antibody-based Therapeutic, Alzheimer's Disease, IND Filing, Pre-clinical Development, Brain Disease, Immune System Targeting, University Collaboration, Rhode Island Ecosystem, Therapeutic Strategy, Neurosciences Research, Drug Development
Website
affibody.com mindimmune.com
Affibody AB logo

About Affibody AB

Affibody AB, founded in 1998 by researchers from the Royal Institute of Technology and the Karolinska Institute, is a private, clinical-stage biotech company based in Stockholm, Sweden. The company operates within the Biotechnology and Health Care industries, focusing on next-generation biotherapeut...

MindImmune Therapeutics, Inc. logo

About MindImmune Therapeutics, Inc.

MindImmune Therapeutics, Inc. is a biotechnology startup founded in 2016, headquartered in the United States. The company is focused on neuro-inflammation, with a primary emphasis on targeting Alzheimer's disease (AD). MindImmune's lead program involves an antibody-based therapeutic aimed at inhibit...

We will tell you when either one moves

BounceWatch watches Affibody AB and MindImmune Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Affibody AB and MindImmune Therapeutic... — by email.

Frequently Asked Questions

Affibody AB. MindImmune Therapeutics, Inc.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Affibody AB has raised $220.00M while MindImmune Therapeutics, Inc. has raised $13.65M.
Affibody AB and MindImmune Therapeutics, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Affibody AB with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Affibody AB on 15 Jun 2026, and MindImmune Therapeutics, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes